3 min read
Measuring What Can't Be Seen: How PTSD Clinical Trials Prove a Drug Works
When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...
Join Us for an Exclusive Conference on Product Launch Readiness - Lausanne, 24th October 2024, 17:00 CET
ADC Therapeutics, together with its partners Veristat, Supply Chain Operations, and PrimeTax, cordially invite you to here and exchange about:
“Product Launch Readiness: Key Cross-Functional Activities to Transition or Optimize Your Organization for Commercial Success”
In April 2021, Zynlonta™ received FDA approval in the US, followed by conditional marketing authorization in Europe in December 2022. This one-hour session will take you through ADC Therapeutics’ journey in preparing for the successful European launch of Zynlonta™, highlighting the importance of cross-functional expertise, coordinated teamwork, strategic partnerships, and careful planning.
With insights from ADC Therapeutics, Veristat, Supply Chain Operations, and PrimeTax, the event will explore critical milestones, challenges, and strategies to consider for launching any life sciences product and optimizing commercial operations.
17:00 – Welcome
17:05 – Product Launch Readiness: Key Cross-Functional Activities to Transition or Optimize Your Organization for Commercial Success
Gaspard Jouandon, Senior Director, Supply Chain Partner Management (exUS), ADC Therapeutics
Ausma Termanis, Associate Director Quality Assurance, Veristat
Tim Foetisch, VP Business Development, Supply Chain Operations
Dominic Nazareno, Partner, PrimeTax
17:45 - Q&A Session
18:00 - Apéritif, Snacks & Networking
20:00 - Event Conclusion
Gain firsthand insights into the complexities of launching a life sciences product. Learn from the Zynlonta™ success story and discover how to apply these lessons to your own projects. Plus, take advantage of the opportunity to network with industry professionals from ADC Therapeutics, Veristat, Supply Chain Operations, PrimeTax, and more during the networking session.
Meet with us at the Product Launch Readiness in Europe event by filling out the form below
3 min read
Apr 27, 2026 Veristat Blog
When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...
3 min read
Apr 24, 2026 Veristat Blog
In August 2024, the FDA declined to approve MDMA-assisted therapy for post-traumatic stress disorder. The decision...